Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HUMA
HUMA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HUMA News
Humacyte Reports Q4 Net Income of -$24.804 Million, Exceeding IBES Estimate of -$23.3 Million
3d ago
moomoo
Humacyte Reports 2025 Financial Results and Pipeline Updates
3d ago
NASDAQ.COM
Humacyte Q4 Earnings Report Analysis
3d ago
seekingalpha
Humacyte Reports Q4 2025 Financial Results and Business Update
3d ago
Newsfilter
Humacyte to Announce Q4 Earnings on March 27
4d ago
seekingalpha
Humacyte Submits Marketing Authorization Application in Israel
Mar 20 2026
Yahoo Finance
Health Care Stocks Decline on Thursday Afternoon
Mar 19 2026
Yahoo Finance
Humacyte Plans to Sell 25 Million Shares to Raise $20 Million
Mar 19 2026
stocktwits
Humacyte Secures $1.475 Million Purchase Commitment for Symvess
Mar 19 2026
seekingalpha
Eligibility Verification for Huma Open Season 3 Airdrop
Feb 25 2026
moomoo
Humacyte Secures Congressional Funding for Bioengineered Vessels
Feb 09 2026
seekingalpha
Humacyte Secures DOD Funding for Bioengineered Blood Vessels
Feb 09 2026
stocktwits
BTIG Affirms Buy Rating on Humacyte, Keeps $6 Price Target Intact
Nov 21 2025
Benzinga
D. Boral Capital Reiterates Buy Rating on Humacyte with $25 Price Target Intact
Nov 20 2025
Benzinga
Benchmark Reaffirms Buy Rating on Humacyte, Adjusts Price Target to $11
Nov 13 2025
Benzinga
D. Boral Capital Reiterates Buy Rating on Humacyte with $25 Price Target Intact
Nov 12 2025
Benzinga
Show More News
